Macquarie Group
RCUS icon

Macquarie Group’s Arcus Biosciences RCUS Stock Holding History

Macquarie Group’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-379,100
Closed -$5.16M – 1358
2025
Q3 		$5.16M Hold
379,100
– – 0.01% 947
2025
Q2 		$3.09M Hold
379,100
– – ﹤0.01% 1093
2025
Q1 		$2.98M Hold
379,100
– – ﹤0.01% 1109
2024
Q4 		$5.64M Hold
379,100
– – 0.01% 924
2024
Q3 		$5.8M Hold
379,100
– – 0.01% 934
2024
Q2 		$5.77M Hold
379,100
– – 0.01% 940
2024
Q1 		$7.16M Hold
379,100
– – 0.01% 883
2023
Q4 		$7.24M Hold
379,100
– – 0.01% 886
2023
Q3 		$6.8M Hold
379,100
– – 0.01% 863
2023
Q2 		$7.7M Hold
379,100
– – 0.01% 848
2023
Q1 		$6.92M Hold
379,100
– – 0.01% 875
2022
Q4 		$7.84M Sell
379,100
-758
-0.2% -$20.9K 0.01% 887
2022
Q3 		$9.94M Sell
379,858
-22
-0% -$582 0.01% 829
2022
Q2 		$9.63M Hold
379,880
– – 0.01% 873
2022
Q1 		$12M Hold
379,880
– – 0.01% 892
2021
Q4 		$15.4M Sell
379,880
-82,100
-18% -$3.18M 0.01% 833
2021
Q3 		$16.1M Sell
461,980
-1,418
-0.3% -$44.1K 0.01% 820
2021
Q2 		$12.7M Hold
463,398
– – 0.01% 880
2021
Q1 		$13M Buy
463,398
+1,034
+0.2% +$36K 0.02% 654
2020
Q4 		$12M Hold
462,364
– – 0.02% 655
2020
Q3 		$7.92M Buy
462,364
+61,200
+15% +$1.37M 0.01% 704
2020
Q2 		$9.93M Buy
+401,164
New +$10.8M 0.02% 634

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Macquarie Group's RCUS Position: Q4 2025 in Review

Macquarie Group sold out of Arcus Biosciences (RCUS) in Q4 2025, closing a stake of 379,100 shares — an estimated $5.16M sold.

Macquarie Group first reported a position in RCUS in Q2 2020 and held it in 22 quarters. The position peaked at $16.1M in Q3 2021. 209 funds tracked by Wall St. Rank hold RCUS as of Q4 2025.

  • Macquarie Group reported no remaining Arcus Biosciences position as of Q4 2025 after selling out during the quarter.
  • Macquarie Group sold 379,100 Arcus Biosciences shares in Q4 2025, an estimated $5.16M.
  • Macquarie Group first reported a position in Arcus Biosciences in Q2 2020 and held it in 22 quarters.
  • Macquarie Group's Arcus Biosciences position peaked at $16.1M in Q3 2021.
  • 209 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.